Lars Erik Bryld
Clinical Associate Professor
1 - 2 out of 2Page size: 10
- 2015
- Published
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort
Ahlehoff, O., Skov, L., Gislason, Gunnar Hilmar, Gniadecki, R., Iversen, L., Bryld, Lars Erik, Lasthein, S., Lindhardsen, J., Kristensen, S. L., Torp-Pedersen, C. & Hansen, P. R., Jun 2015, In: Journal of the European Academy of Dermatology and Venereology. 29, 6, p. 1128-34 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
Gniadecki, R., Bang, B., Bryld, Lars Erik, Iversen, L., Lasthein, S. & Skov, Lone, Jan 2015, In: British Journal of Dermatology. 172, 1, p. 244-252 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 32369880
Most downloads
-
77
downloads
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
18
downloads
Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
11
downloads
Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published